DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment

 

 

Molecular Imaging Homepage

BWXT to acquire Sotera Health’s Nordion medical isotope business $150M in capital expenditures expected this year

Canada forms council for radioisotope production Seeks to raise awareness about importance of medical isotope production to the public

Imaging innovation yields new insights into cardiac health As ultrasound analytics increase, other cardiac imaging tools become more accurate and affordable

NVIDIA aims to bring AI insights to existing global fleet of imaging systems With Project Clara, older scanners may gain remote access to latest capabilities

New PET imaging agent may help guide treatment for neurodegenerative diseases Preclinical study generates favorable results

MGH researchers develop AI technique for fast, high-quality imaging scans Image reconstruction in a fraction of a second

CereMetrix Silver neuroimaging analytics platform scores FDA approval Quantifies brain function down to the voxel level

New PET imaging agent predicts tumor response to lung cancer drug Could lead to better patient management and outcomes

PET beats SPECT for detecting coronary artery disease: study Detected 79 percent of severe obstructive cases versus 70 percent

PET/MR and the future of pediatric chemotherapy Dr. Ashok Joseph Theruvath, postdoctoral research fellow in the Molecular Imaging Program at the Stanford School of Medicine discusses promising research for assessing pediatric chemo outcomes

Could be used for other
mental disorders

Researchers develop PET tracer that may predict effectiveness of depression treatment

por Lauren Dubinsky , Senior Reporter
A new PET tracer can determine ahead of time whether a drug can successfully treat major depressive disorder (MDD), according to a study published in the April issue of The Journal of Nuclear Medicine.

“In this study we use a PET tracer that targets the serotonin transporter, an important protein within the serotonergic system,” Dr. Mala R. Ananth of Stony Brook University in New York, told HCB News. “Dysfunction of the serotonergic system is a common hypothesis for the underlying cause of MDD.”

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



In clinical psychiatry, there are currently no objective markers to predict if a treatment will be effective. 11C-DASB PET imaging could change that.

The drug escitalopram, which is a selective serotonin reuptake inhibitor (SSRI), has been shown to be an effective treatment for MDD, but it doesn’t work for every patient. A 11C-DASB PET scan can determine which patients will benefit by measuring the level of serotonin transporter protein present before treatment.

Ananth and her team had 31 healthy participants and 26 untreated patients with MDD receive a 11C-DASB PET scan. The MDD patients then underwent eight weeks of standardized therapy with escitalopram.

They found that patients who responded well to the treatment had less serotonin transporter proteins before treatment began. This suggests that pre-treatment neurobiology could be used to predict treatment response.

“Here we find that patients with MDD who achieve remission following treatment with a specific SSRI (escitalopram) exhibit differences in the serotonin transporter in a region important for emotional processing prior to treatment,” said Ananth.

She added that these findings may be applicable for any disorder in which SSRIs are used, including obsessive-compulsive disorder, but that further research is needed to confirm that.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS